Clinical Trial Update: Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease

View source ↗

Summary

The trial assessing serum NGAL in chronic kidney disease and acute kidney injury has completed at Hillerød Hospital, Denmark.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Injury

Snippet

Sponsor: Hillerod Hospital, Denmark | Conditions: Chronic Kidney Diseases, CKD | Status: COMPLETED